Literature DB >> 6424422

Effects of non-steroidal anti-inflammatory drugs on lymphocyte activation.

A T Ali, J M Hanson, J Morley.   

Abstract

Guinea-pig lymph node lymphocytes were stimulated with mitogen (phytohaemagglutinin) in vitro and lymphocyte activation was measured by tritiated thymidine incorporation (DNA synthesis). Inclusion of non-steroidal anti-inflammatory drugs (NSAIDs) in the culture medium at therapeutic concentrations, frequently exerted an inhibitory effect. Such inhibition could not be attributed to the ability of these drugs to inhibit cyclo-oxygenase or lipoxygenase enzymes. Inhibition by salicylates was not associated with cytotoxic or cytopathic effects, since inhibition was only evident when the drugs were included in the early phase of culture. Other NSAIDs exhibited varying degrees of toxicity, which in some instances may account for observed inhibition. The effects on lymphocyte activation of selective inhibitors of pathways of arachidonic acid metabolism, do not support the proposition that the generation of prostaglandins, thromboxanes, leukotrienes or related compounds is an obligatory step during lymphocyte activation.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6424422     DOI: 10.1007/bf01966645

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  40 in total

1.  Differentiation of the effects of preincubation and indomethacin on lymphocyte transformation.

Authors:  P G Sohnle; C Collins-Lech
Journal:  Clin Immunol Immunopathol       Date:  1979-05

2.  Resolution of prostaglandin endoperoxide synthase and thromboxane synthase of human platelets.

Authors:  S Hammarström; P Falardeau
Journal:  Proc Natl Acad Sci U S A       Date:  1977-09       Impact factor: 11.205

3.  Modulation of lymphocyte activation. I. Inhibition by an oxidation product of arachidonic acid.

Authors:  M G Goodman; W O Weigle
Journal:  J Immunol       Date:  1980-08       Impact factor: 5.422

4.  Enhancement of lymphocyte activation by BW755C in vitro.

Authors:  A T Ali; J Morley
Journal:  Agents Actions       Date:  1982-12

5.  Effect of inhibitors of arachidonic acid metabolism on mitogenesis in human lymphocytes: possible role of thromboxanes and products of the lipoxygenase pathway.

Authors:  J P Kelly; M C Johnson; C W Parker
Journal:  J Immunol       Date:  1979-04       Impact factor: 5.422

6.  Prostaglandin and thromboxane production by human and guinea-pig macrophages and leucocytes.

Authors:  J Morley; M A Bray; R W Jones; D H Nugteren; D A van Dorp
Journal:  Prostaglandins       Date:  1979-05

7.  Effects of arachidonic acid and other unsaturated fatty acids on mitogenesis in human lymphocytes.

Authors:  J P Kelly; C W Parker
Journal:  J Immunol       Date:  1979-04       Impact factor: 5.422

8.  Prostaglandin production by macrophages and the effect of anti-inflammatory drugs.

Authors:  M A Bray; D Gordon
Journal:  Br J Pharmacol       Date:  1978-08       Impact factor: 8.739

9.  Effects of certain antirheumatic drugs on normal human peripheral blood lymphocytes. Inhibition of mitogen- and antigen-stimulated incorporation of tritiated thymidine.

Authors:  R S Panush
Journal:  Arthritis Rheum       Date:  1976 Sep-Oct

10.  Suppression of human T-cell mitogenesis by prostaglandin. Existence of a prostaglandin-producing suppressor cell.

Authors:  J S Goodwin; A D Bankhurst; R P Messner
Journal:  J Exp Med       Date:  1977-12-01       Impact factor: 14.307

View more
  3 in total

1.  Suppression of mitogen- and antigen-induced lymphocyte proliferation by lanthanides.

Authors:  M Yamage; C H Evans
Journal:  Experientia       Date:  1989-12-01

2.  Modeling Combined Immunosuppressive and Anti-inflammatory Effects of Dexamethasone and Naproxen in Rats Predicts the Steroid-Sparing Potential of Naproxen.

Authors:  Xiaonan Li; Debra C DuBois; Dawei Song; Richard R Almon; William J Jusko; Xijing Chen
Journal:  Drug Metab Dispos       Date:  2017-04-17       Impact factor: 3.922

3.  Equipotent inhibition by R(-)-, S(+)- and racemic ibuprofen of human polymorphonuclear cell function in vitro.

Authors:  M Villanueva; R Heckenberger; H Strobach; M Palmér; K Schrör
Journal:  Br J Clin Pharmacol       Date:  1993-03       Impact factor: 4.335

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.